News Related to Interleukin-13

Related coverage linked through entity extraction aliases.

Dupilumab Phase 2 Trial Shows Significant Improvements for Eosinophilic Gastritis

Jun 29, 2026

A phase 2 clinical trial published in The Lancet Gastroenterology & Hepatology found that dupilumab significantly improved symptoms and biological markers in patients with eosinophilic gastritis, a rare stomach disease with no approved treatments. The DEGAS study involved 41 patients across 11 U.S. centers.

Eli Lilly Reports Positive Phase 3 Results for Three Drug Programs

Mar 16, 2026

Eli Lilly announced positive Phase 3 results for EBGLYSS in pediatric atopic dermatitis, orforglipron in diabetes showing superiority over Rybelsus, and Retevmo in early-stage lung cancer, expanding potential indications across its portfolio.